TalarMade Receives Strategic Investment from Rockpool to Boost Growth

TalarMade is pleased to announce a strategic investment from Rockpool Investments, marking an exciting milestone in our journey as a fast-growing provider of medical devices and clinical services.

This partnership represents a strong vote of confidence in TalarMade’s growth strategy, people, and long-term vision. With Rockpool’s backing, we will accelerate our expansion plans, enhance innovation across our product lines, and continue delivering high-quality, evidence-based solutions to healthcare professionals and patients across the UK.

At TalarMade, we specialise in orthotics and pressure care products, serving both NHS and private sector healthcare providers. Our in-house clinical expertise underpins our product development, ensuring that everything we offer is designed with medical evidence, regulatory compliance, and improved patient outcomes in mind.

Over the past two decades, we have built a reputation as a trusted brand in the UK healthcare market – both for our own-brand medical devices and as a distributor of specialist brands. We also provide clinical services within the NHS, providing specialist patient assessment and treatment for musculoskeletal conditions across several clinics nationwide.

TalarMade was founded by Chairman Bernie Crewdson in 2002 and is led by CEO Ryan Thomas. Rockpool is investing alongside the existing management team and is backing TalarMade’s ambitious expansion plans with new growth capital.

This transaction marks Rockpool’s third recent investment in the healthcare sector, following Harley Academy in February 2024 and Oxford Online Pharmacy in August 2024. The investment was led by Tom Coey (Partner), Toby Hurdle (Investment Manager), and Ryan McTigue (Investment Associate).

Ryan Thomas, CEO of TalarMade, commented:
Rockpool’s investment is a strong vote of confidence in our strategy, people, and future. With their backing, we’ll accelerate our growth and continue delivering innovative, evidence-based products. Our leadership team and core values remain unchanged, ensuring continuity for our staff and distribution partners with a commitment to deliver the same high standards our customers expect.”

Bernie Crewdson, Founder & Chairman of TalarMade, added:
I am excited for the opportunities ahead of TalarMade. The injection of investment and support from Rockpool will enable the team to accelerate the growth of the business I founded over 20 years ago. I have confidence in Ryan and the leadership team to continue my legacy and look forward to sharing in the success.”

Tom Coey, Partner at Rockpool, said:
TalarMade’s reputation for clinical excellence and product innovation makes it a standout business in the UK healthcare market. We look forward to supporting Ryan and his team as TalarMade expands into new geographies, pursues strategic acquisitions, and continues to deliver high-quality, evidence-based products for healthcare professionals and patients alike.”